Αποτελέσματα Αναζήτησης
6 Μαρ 2024 · A twice-yearly injectable formulation (Sunlenca) was approved in 2022 for treatment-experienced people with multidrug-resistant HIV. Gilead also makes a 300mg lenacapavir pill that is taken as an initial loading dose and can be used for temporary ‘bridging’ if an injection must be missed.
- Top 5 stories on new drugs for HIV prevention and treatment ... - Aidsmap
At the Conference on Retroviruses and Opportunistic...
- Top 5 stories on new drugs for HIV prevention and treatment ... - Aidsmap
4 Ιαν 2023 · Sunlenca is the first of a new class of drugs called capsid inhibitors to be FDA-approved for treating HIV-1. Sunlenca works by blocking the HIV-1 virus’ protein shell (the capsid), thereby interfering with multiple essential steps of the viral lifecycle.
14 Μαρ 2023 · At the Conference on Retroviruses and Opportunistic Infections (CROI 2023) in February, many researchers presented studies looking at new drugs being tested for use as treatment, pre-exposure prophylaxis (PrEP), and post-exposure prophylaxis (PEP). Here are some highlights.
23 Δεκ 2021 · The Food and Drug Administration has approved the first injectable medication for HIV prevention. Health advocates say it could be a game changer in protecting people against AIDS
23 Δεκ 2021 · Apretude, a new drug approved by the FDA this week, is an injection that has proven to be significantly more effective at reducing the risk of sexually-acquired HIV.
18 Νοε 2021 · Thousands of people with HIV will now be offered a new long-acting injection to manage their condition if they would prefer to stop taking daily pills. Charities have welcomed the approval of...
FDA today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection.
